18
May 2026
Once-nightly oral pill helps control obstructive sleep apnea
A once-nightly oral pill helped control obstructive sleep apnea in a large, phase 3 clinical trial presented at the 2026 ATS International Conference.
STAY INFORMED!
18
May 2026
Surgical training program for community health officers slashes maternal mortality risk
Maternal mortality in Sierra Leone used to be among the highest in the world. A 15-year-old non-profit program that trains community health officers to do life-saving surgeries has helped slash that risk by two-thirds.
18
May 2026
Health experts outline symptoms and risks of shipboard hantavirus
It's one of the cruisegoer's biggest fears: a contagious disease outbreak at sea.
18
May 2026
Gut microbiome metabolite butyrate relieves chronic jaw joint pain
Temporomandibular joint (TMJ) pain is associated with disrupted gut microbiome metabolites. Researchers reveal that butyrate, administered as tributyrin, alleviates pain by restoring histone acetylation and reversing gene regulatory changes in the brain.
Why Us?
Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.